Company

News Releases

Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archived press releases are made available for informational purposes only.  Press releases may contain certain forward-looking statements that are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.  Archived press releases are current only as of the date of issue and BioPharmX assumes no obligation to update information contained in archived press releases.

 

Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014

2017 Archives

Dec 7, 2017
Dec 4, 2017
Cellular analysis suggests minocycline's antimicrobial properties and ability to modulate inflammatory cytokine secretion make it uniquely effective
Nov 21, 2017
Nov 8, 2017
Oct 18, 2017
Topical Minocycline Gel Offers Potential Advantages in the Treatment of Inflammatory Skin Diseases
Oct 11, 2017
Researchers use nonlinear optical imaging modality to potentially quantify local concentrations of minocycline for the first time
Sep 13, 2017
Company reports continued progress in clinical programs
Sep 12, 2017
Data suggest feasibility of BPX-01 1% and 2% in patients with rosacea
Sep 5, 2017
Jul 27, 2017
Jul 13, 2017
Jun 22, 2017
BPX-01 2% formulation reduced inflammatory lesions by 59%
Jun 14, 2017
Jun 13, 2017
Webcast and conference call begins today at 1:30 p.m. PT/4:30 p.m. ET
Jun 7, 2017
Conference call scheduled for Tuesday, Jun. 13 at 1:30 p.m. PT/4:30 p.m. ET
Jun 1, 2017
- Phase 2b study demonstrates 59% reduction in number of acne lesions using BPX-01 2% vs. 44% in vehicle
May 11, 2017
- Company to present comprehensive results of BPX-01 phase 2b trial
May 3, 2017
Achieves Statistical Significance for Primary Endpoint in Phase 2b Acne Study
Apr 28, 2017
Apr 26, 2017
Apr 20, 2017
Mar 30, 2017
Research suggests molecular iodine specifically targets certain types of breast cancer cells, suggests strong anti-proliferative effects
Mar 23, 2017
Management will host webcast and conference call today at 1:30 p.m. PT/4:30 p.m. ET
Mar 21, 2017
Mar 16, 2017
Conference call scheduled for Thursday, Mar. 23 at 1:30 p.m. PT/4:30 p.m. ET
 

print email rss